Tumor-derived MUC1 mucins interact with differentiating monocytes and induce IL-10highIL-12low regulatory dendritic cell.
about
A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in CancerIntra- and Extra-Cellular Events Related to Altered Glycosylation of MUC1 Promote Chronic Inflammation, Tumor Progression, Invasion, and MetastasisThe dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.Sialyl-tn in cancer: (how) did we miss the target?Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis.Distribution and function of macrophage galactose-type C-type lectin 2 (MGL2/CD301b): efficient uptake and presentation of glycosylated antigens by dendritic cellsComplex role for the immune system in initiation and progression of pancreatic cancer.Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive disease.Glioma stem cell-targeted dendritic cells as a tumor vaccine against malignant glioma.Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages.How tolerogenic dendritic cells induce regulatory T cellsPancreatic ductal adenocarcinoma: a review of immunologic aspects.CCAAT/enhancer binding protein-δ expression by dendritic cells regulates CNS autoimmune inflammatory disease.Dendritic cell dysfunction in cancer: a mechanism for immunosuppression.Dendritic cells and tumor microenvironment: a dangerous liaisonHigher susceptibility to experimental autoimmune encephalomyelitis in Muc1-deficient mice is associated with increased Th1/Th17 responses.Hepatocyte nuclear factor 4alpha in the intestinal epithelial cells protects against inflammatory bowel diseaseImmunodeficiency and immunotherapy in multiple myeloma.Mucins help to avoid alloreactivity at the maternal fetal interface.MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma.Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy.Urokinase-mediated recruitment of myeloid-derived suppressor cells and their suppressive mechanisms are blocked by MUC1/sec.MUC1 mucin: a peacemaker in the lung.Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy.Killer dendritic cells and their potential for cancer immunotherapy.MUC1 immunotherapy.The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced toleranceDendritic cells and multiple sclerosis: disease, tolerance and therapy.Tumour immunomodulation: mucins in resistance to initiation and maturation of immune response against tumours.What are the molecules involved in regulatory T-cells induction by dendritic cells in cancer?Tumor-altered dendritic cell function: implications for anti-tumor immunity.Mechanisms of antitumor and immune-enhancing activities of MUC1/sec, a secreted form of mucin-1.Seed-in-Soil: Pancreatic Cancer Influenced by Tumor Microenvironment.Suppression of vascular endothelial growth factor abrogates the immunosuppressive capability of murine gastric cancer cells and elicits antitumor immunity.Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells.PD-1 Suppresses Development of Humoral Responses That Protect against Tn-Bearing Tumors.Immunotherapy in gastrointestinal cancersMucin-induced apoptosis of monocyte-derived dendritic cells during maturation.Lung squamous cell carcinoma and adenocarcinoma cell lines use different mediators to induce comparable phenotypic and functional changes in human monocyte-derived dendritic cells.Investigation of a new tumor-associated glycosylated antigen as target for dendritic cell vaccination in pancreatic cancer.
P2860
Q26751472-E0AFBB97-2ADE-4ACD-99C3-7CBEAD2E5D40Q28066445-6BFAD1C6-BB01-435C-A846-ED5C7ADA5FD6Q30317628-985D1667-3BEE-4AA6-9BC6-702A2968B01DQ33649572-1472DE5B-CB79-4432-960C-EACC012DBAFFQ33811691-736C0928-4023-421C-8AE0-9134CFE2BD9FQ33911282-3F21FFAD-32DA-4CE4-9BFE-9D5C8D316064Q34093784-C39A1E83-EA25-4AFA-ABE3-E26276EA3CC2Q34178740-00E36052-92AD-4D4F-94F3-EAE72D3AE165Q34504805-F34A2759-9EE4-4CF1-93E4-FA64E107938FQ34571570-55249C4C-DAAB-4884-BE58-FBD26E028ACAQ34631825-6828CF59-5789-460F-A302-9F7456EB2E8AQ35870682-F8A37B63-CEA2-4ED2-A342-E7F8113E9D48Q35906729-F3A82010-A4D7-46C9-BEB6-EFC86BADC5C6Q36262281-2329FBEA-4A29-4473-BAE9-51BCDF6060F7Q36569018-FA7DA5DE-DEA6-430C-A00A-EA379DFF1720Q36653456-22C8842D-E091-4125-94D4-9FC7378003B2Q36732009-FB74082C-4992-4FB0-8E27-0815E8091414Q36904977-082BE2A0-4BBF-4958-B471-5451186C660EQ36995323-CD982900-4811-42B5-AD83-809C8A3E5D4FQ37059144-D6AAC418-D628-4E70-83DE-E05DDDC017BFQ37079110-577C3524-C4E5-4203-A3C8-2EDC1C94F928Q37187551-46A53258-0B69-48E4-8903-40E7427ED333Q37212643-526AF41B-2637-4C40-BF4F-FDFD1A3A584FQ37513293-448BF5B1-D164-4DF7-B1CB-E88CFE8FE708Q37556082-8C7BE89A-7EA3-48A0-BF0F-1F25A5944363Q37773241-415CAB63-E056-4390-8410-D0B10EA8D5ADQ37959968-8F2EEC17-5009-4CE9-BEBF-FE5414376BB1Q38070093-A0498FAD-CF4B-4820-919F-3C69FEA825BCQ38072479-9B364B1B-EFA8-4AD6-832D-6C8B9AC3C5A1Q38114070-A20F060C-1526-4CE8-AA58-E996414A9E40Q38123166-D96AA4B2-A823-46D8-B235-E049E65C0195Q38162151-BF53922B-116F-4471-98F7-CD99572D07B3Q38650250-E7D148C2-C0A3-412D-BD25-4F058921E002Q38973919-EB63DA9B-E461-4A24-A7AA-B47DB2C8997DQ39013095-0DB1E9F7-6BC2-49A5-8823-942B408FBD58Q39179715-A75D7B5C-3590-4C2F-8FD6-8DAA7B9F90EDQ39453597-CBF09A2A-32EA-4CFA-BEF6-C815BF35A58BQ39952413-0D10E50F-C316-4FC2-8D97-19D11A7944E4Q40379577-85F7D0F5-B002-47F8-B492-85177B935671Q41876001-AE932C20-4402-4C80-B1E8-8A492BE1C1AE
P2860
Tumor-derived MUC1 mucins interact with differentiating monocytes and induce IL-10highIL-12low regulatory dendritic cell.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Tumor-derived MUC1 mucins inte ...... low regulatory dendritic cell.
@en
type
label
Tumor-derived MUC1 mucins inte ...... low regulatory dendritic cell.
@en
prefLabel
Tumor-derived MUC1 mucins inte ...... low regulatory dendritic cell.
@en
P2093
P1476
Tumor-derived MUC1 mucins inte ...... low regulatory dendritic cell.
@en
P2093
Alessandro Zerbi
Alessia Mercalli
Biagio Eugenio Leone
Gianpaolo Balzano
Marina Pontillo
Paola Allavena
Paolo Monti
Silvia Cainarca
Valeria Sordi
Valerio Di Carlo
P304
P356
10.4049/JIMMUNOL.172.12.7341
P407
P577
2004-06-01T00:00:00Z